Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioblastoma × aflibercept × Clear all

Sponsor

Conditions

Neoplasm Metastasis 9 Colorectal Neoplasms 7 Rectal Neoplasms 5 Colorectal Cancer Metastatic 5 Ovarian Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Colonic Neoplasms 3 Uveal Melanoma 2 Melanoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neurofibromatosis 2 1 Myeloproliferative Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Macular Degeneration 1 Lung Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Fibrolamellar hepatocellular carcinoma 1

Interventions

Temozolomide 104 Bevacizumab 64 Radiotherapy 45 Radiation 21 Erlotinib Hydrochloride 12 pembrolizumab 10 Magnetic Resonance Spectroscopy 10 Lomustine 10 Vorinostat 9 Irinotecan 9 Nivolumab 8 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 7 Immunoglobulin G 7 Disulfides 7 Sorafenib 6 Radiotherapy, Conformal 6 Radiosurgery 6 Drug Therapy 6 Carmustine 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Everolimus 5 veledimex 4 selinexor 4 sargramostim 4 cediranib 4 Dasatinib 4 Cilengitide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡